Doi.org/10.1126/scitranslmed.aaf3124
Jump to navigation
Jump to search
Target Article[edit | edit source]
Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin; Yanqing Liu et al.; Science Translational Medicine; 2016; https://doi.org/10.1126/scitranslmed.aaf3124
Article providing comments[edit | edit source]
Comment on “Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin”; Winter, Stefan; Fisel, Pascale; Büttner, Florian; Nies, Anne T.; Stenzl, Arnulf; Bedke, Jens; Schwab, Matthias; Schaeffeler, Elke; ; Science Translational Medicine; 2017-5-24 https://doi.org/10.1126/scitranslmed.aal2439
Summary[edit | edit source]
Note: Opened to append information.